Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In vitro characterization and enhancement of HIV-specific CD8+ T cells
NL-OMON42584Withdrawn
- Sponsor
- Erasmus MC
- Start
- Sep 2015
- Countries
- 1
01
Overview
Open-label, single-arm trial in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS), sponsored by Erasmus MC. Primary endpoints: Phenotypic and functional characterization of virus-specific CD8+ T cells, Reversal of exhaustion phenotype by epigenetic inhibitors and 1 more. Planned start Sep 2015; status: withdrawn.
02
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on NL-OMON42584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42584.